ORENCIA Go Patient Materials
Learn more about your treatment with ORENCIA® (abatacept)
UPDATE: RESOLUTION OF ORENCIA (ABATACEPT) SHORTAGE
BMS Australia is pleased to advise that the Orencia (abatacept) subcutaneous (SC) presentations shortage has been resolved. What this means is:
BMS wishes to thank patients, their treating physicians, and pharmacists for their patience, understanding and support during this extremely challenging situation. We recognise that the need to reduce the usage of Orencia during this time has been difficult for all to achieve and we wish to convey our sincerest appreciation.
BMS would also like to extend our thanks to the TGA, Australian Rheumatology Association and Arthritis Australia as well as Creaky Joints for their collaboration and support during this time.
BMS knows the importance of a steady and reliable supply of critical medicines for patients and remains committed to delivering Orencia to patients in Australia.
Learn more about how to administer the Orencia Clickject Autoinjector
Learn more about how to administer the Orencia Safety Syringe